Alnylam's Q2 Revenues Soar as Losses Decline; Firm Gives Update on Pipeline, microRNA Work
Alnylam's Q2 Revenues Soar as Losses Decline; Firm Gives Update on Pipeline, microRNA Work
By Doug Macron
July 27, 2006
RNAi News
The company remains on track to sign two more out-licensing deals for its IP in the research field before year end, bringing the total number of licensees for the year to five.
Paid subscription is required to view article.
